Literature DB >> 7616225

Visualization of antipsychotic drug binding to living mesolimbic neurons reveals D2 receptor, acidotropic, and lipophilic components.

S Rayport1, D Sulzer.   

Abstract

To examine the binding of antipsychotic drugs to living neurons, we applied fluoroprobe derivatives of the D2 antagonist spiperone to mesolimbic system neurons in postnatal culture. We found that rhodamine-N-(p-aminophenethyl)spiperone (rhodamine-NAPS) stereospecifically labeled the plasma membranes of 38 +/- 6% of ventral tegmental area neurons, 22 +/- 7% of which were dopaminergic, and 50 +/- 6% of medium-sized putatively GABAergic nucleus accumbens neurons, with a time constant of approximately 8 min. In contrast, the BODIPY derivative of NAPS rapidly labeled intracellular sites in all neurons in a punctate pattern, consistent with acidotropic uptake. Native antipsychotics also show acidotropic uptake, which we visualized by their displacement of the fluorescent weak base vital dye acridine orange from acidic intracellular compartments. We found that acidotropic uptake correlated best with the partition coefficients of the drugs. With a time constant of 23 min, rhodamine-NAPS labeled all neurons in a pattern suggestive of lipophilic solvation. Thus, initially rhodamine-NAPS makes possible visualization of D2 receptors on living neurons; however, acidotropic uptake and lipophilic solvation obscure receptor labeling and may account for time-dependent factors in the action of antipsychotic drugs, as well as affect their use as radioreceptor ligands.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616225     DOI: 10.1046/j.1471-4159.1995.65020691.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Authors:  E N Pothos; K E Larsen; D E Krantz; Y Liu; J W Haycock; W Setlik; M D Gershon; R H Edwards; D Sulzer
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

2.  Vesicular Antipsychotic Drug Release Evokes an Extra Phase of Dopamine Transmission.

Authors:  Seth H Walters; Edwin S Levitan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 3.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

Review 4.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

5.  Dopamine neurons make glutamatergic synapses in vitro.

Authors:  D Sulzer; M P Joyce; L Lin; D Geldwert; S N Haber; T Hattori; S Rayport
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

6.  Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.

Authors:  Kristal R Tucker; Ethan R Block; Edwin S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

7.  Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of medium-spiny neurons in the nucleus accumbens.

Authors:  Takeo Mizuno; Claudia Schmauss; Stephen Rayport
Journal:  BMC Neurosci       Date:  2007-01-19       Impact factor: 3.288

8.  Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats.

Authors:  Taygun C Uzuneser; Eva-Maria Weiss; Jana Dahlmanns; Liubov S Kalinichenko; Davide Amato; Johannes Kornhuber; Christian Alzheimer; Jan Hellmann; Jonas Kaindl; Harald Hübner; Stefan Löber; Peter Gmeiner; Teja W Grömer; Christian P Müller
Journal:  J Psychopharmacol       Date:  2020-12-04       Impact factor: 4.153

9.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08

10.  A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter.

Authors:  Davide Amato; Fabio Canneva; Paul Cumming; Simone Maschauer; Dominik Groos; Jana Katharina Dahlmanns; Teja W Grömer; Lisa Chiofalo; Marc Dahlmanns; Fang Zheng; Johannes Kornhuber; Olaf Prante; Christian Alzheimer; Stephan von Hörsten; Christian P Müller
Journal:  Mol Psychiatry       Date:  2018-07-23       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.